Patents by Inventor Shudong Wang

Shudong Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11970491
    Abstract: A novel class of inhibitors of protein kinates that are useful in the treatment of cell proliferative diseases and conditions, and especially those characterised by over-expression of CDK4, CDK6 and/or cyclin D, including certain cancers of lung, breast, brain, central nervous system, colorectal cancer and leukaemias.
    Type: Grant
    Filed: August 31, 2021
    Date of Patent: April 30, 2024
    Assignee: AUCENTRA THERAPEUTICS PTY LTD
    Inventors: Shudong Wang, Solomon Tadesse Zeleke, Mingfeng Yu
  • Publication number: 20240089879
    Abstract: The present disclosure discloses a time service and positioning network system for an underground chain-shaped large space in a coal mine. The system adopts a base station-level network internal time synchronization method which takes an optical fiber time service as a main part and takes a satellite time service as an auxiliary part to construct a time service and positioning network system with an unified time within the ad-hoc network base stations, based on the ad-hoc network base stations linearly arranged in the underground chain-shaped large space in the coal mine. Through the network construction, the network stabilization and the network application, the system unifies the time reference of the base station-level network and improves the positioning accuracy of the network application by utilization of the base station-level network internal time synchronization method.
    Type: Application
    Filed: September 30, 2022
    Publication date: March 14, 2024
    Inventors: Gongbo ZHOU, Chuansheng ZHANG, Fan JIANG, Lianfeng HAN, Shudong WANG, Xin LIU, Duifang GU, Tao WANG, Chuansong WANG, Libing WANG, Niansheng LIU, Fuxing SHI, Dongrun LIU, Lizheng LI, Zhencai ZHU
  • Patent number: 11930463
    Abstract: The present disclosure discloses a time service and positioning network system for an underground chain-shaped large space in a coal mine. The system adopts a base station-level network internal time synchronization method which takes an optical fiber time service as a main part and takes a satellite time service as an auxiliary part to construct a time service and positioning network system with an unified time within the ad-hoc network base stations, based on the ad-hoc network base stations linearly arranged in the underground chain-shaped large space in the coal mine. Through the network construction, the network stabilization and the network application, the system unifies the time reference of the base station-level network and improves the positioning accuracy of the network application by utilization of the base station-level network internal time synchronization method.
    Type: Grant
    Filed: September 30, 2022
    Date of Patent: March 12, 2024
    Assignees: CHINA UNIVERSITY OF MINING AND TECHNOLOGY, XUZHIU KERUI MINING TECHNOLOGY CO., LTD.
    Inventors: Gongbo Zhou, Chuansheng Zhang, Fan Jiang, Lianfeng Han, Shudong Wang, Xin Liu, Duifang Gu, Tao Wang, Chuansong Wang, Libing Wang, Niansheng Liu, Fuxing Shi, Dongrun Liu, Lizheng Li, Zhencai Zhu
  • Patent number: 11892441
    Abstract: A transboundary-area water-body monitoring and early warning system includes a monitoring device placed in water body to monitor the water body. The monitoring device comprises a housing body. A control mechanism, a communication mechanism, a sensor and a power box are arranged within the housing body. Power ends of the control mechanism, of the sensor, and of the communication mechanism are electrically connected to an output end of the power box. Control terminals of the communication mechanism and of the sensor are electrically connected to a control terminal of the control mechanism. The control mechanism is configured to receive a signal sent by the sensor, and send the signal from the sensor to a background computer through the communication mechanism. The housing body comprises a lower housing and an upper housing. The lower housing is sealably connected to the upper housing.
    Type: Grant
    Filed: August 12, 2021
    Date of Patent: February 6, 2024
    Assignees: NANJING INSTITUTE OF ENVIRONMENTAL SCIENCES, MINISTRY OF ECOLOGY AND ENVIRONMENT, JIANGSU JHS ENVIRONMENT TECHNOLOGIES CO., LTD.
    Inventors: Chengcheng Ding, Yibin Cui, Jianhua Dai, Nan Shen, Shudong Wang
  • Publication number: 20230399325
    Abstract: Disclosed are salts of N-Cyclopentyl-5-(2-((5-((4-ethylpiperazin-1-yl) methyl) pyridin-2-yl) amino)-5-fluoropyrim-idin-4-yl)-4-methylthiazol-2-amine and polymorphs thereof, which are inhibitors of protein kinases, in particular cyclin-dependent kinase 4/6 (CDK4/6), and can be used to treat proliferative disorders, such as cancer, and other diseases related to protein kinase/CDK activity.
    Type: Application
    Filed: November 10, 2021
    Publication date: December 14, 2023
    Inventors: Shudong WANG, Hui WANG, Jinchen LV, Jun LIU
  • Publication number: 20230339889
    Abstract: 2-oxo-N-(4-(pyrimidin-4-yloxy/thio)phenyl)-1,2-dihydropyridine-3-carboxamide derivatives are disclosed for use in the prevention and/or treatment of proliferative cell diseases and conditions including cancers. The compounds are considered to be capable of inhibiting cell proliferation and cause cancer cell apoptosis by inhibiting the activity of receptor tyrosine kinases (RTKs) such as TYRO3, AXL, MER and/or MET.
    Type: Application
    Filed: July 9, 2021
    Publication date: October 26, 2023
    Inventors: Shudong WANG, Aik Wye GOH
  • Publication number: 20230310427
    Abstract: Methods and uses of Rilpivirine and analogues thereof in the treatment and/or prevention of proliferative cell diseases and conditions are disclosed. Among the diseases and conditions that may be treated and/or prevented, are cancers characterised by Aurora A dysregulation.
    Type: Application
    Filed: June 30, 2021
    Publication date: October 5, 2023
    Inventors: Richard John HEAD, Shudong WANG, Md Saiful ISLAM, Malika KUMARASIRI
  • Publication number: 20230215167
    Abstract: The present disclosure discloses a remote sensing-based extraction method for a type of a river channel, including: obtaining multi-source remote sensing data of a target area including a river channel; preprocessing the multi-source remote sensing data, and obtaining corresponding reflectance data; according to the reflectance data, analyzing a water index and a vegetation index of the target area; and according to the water index and the vegetation index, constructing first preset conditions for determining whether there is water in the river channel and second preset conditions for determining whether the river channel is a non-dry river channel to determine the type of the river channel. Types of river channels can be divided into four types: non-dry river channels, seasonal dry river channels, temporary water channels, and dry river channels.
    Type: Application
    Filed: December 29, 2022
    Publication date: July 6, 2023
    Inventors: Jixi GAO, Sihan LIU, Shudong WANG, Dai'an YOU, Jiahua TENG, Mingyong CAI, Zhuo FU
  • Publication number: 20230181580
    Abstract: A class of thiazole-pyrimidine compounds is disclosed for use in the treatment of proliferative cell diseases and conditions in the CNS including glioblastoma. The compounds are considered to be capable of blocking tumour cell proliferation by inhibiting the activity of CDK4 and/or CDK6 and are capable of crossing the blood brain barrier.
    Type: Application
    Filed: May 5, 2021
    Publication date: June 15, 2023
    Inventor: Shudong WANG
  • Publication number: 20230092876
    Abstract: A novel class of inhibitors of protein kinases useful in the treatment of proliferative cell diseases and conditions including cancers, and especially those characterised by over-expression of CDK8 and/or one or more aberrant CDK8 activity, including certain cancers of lung, breast, brain, ovary, prostate, colorectal cancer and leukaemias. The inhibitors have the general structure I.
    Type: Application
    Filed: April 20, 2022
    Publication date: March 23, 2023
    Inventors: Shudong Wang, Stephen Philip, Mingfeng Yu
  • Patent number: 11566024
    Abstract: Disclosed are a tartrate of 3-(5-fluoro-4-(4-methyl-2-(methylamino)thiazol-5-yl) pyrimidin-2-ylamino)-benzenesulfonamide and a polymorph thereof, which are inhibitors of protein kinases, in particular cyclin-dependent kinase 9 (CDK9), and can be used to treat proliferative disorders, such as cancer, and other diseases related to protein kinase/CDK activity.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: January 31, 2023
    Inventors: Shudong Wang, Hui Wang, Liqun Jiang, Jinchen Lv, Wenjian Ju
  • Publication number: 20220335722
    Abstract: The present disclosure provides methods and systems for vehicle verification. The method may include receiving vehicle verification information related to a vehicle to be verified from a client, wherein the vehicle verification information includes a plurality of images acquired by the client via an imaging device, and the vehicle verification information responds to at least one vehicle verification instruction. The method may further include determining a verification result of the vehicle based on the vehicle verification information.
    Type: Application
    Filed: June 23, 2022
    Publication date: October 20, 2022
    Applicant: BEIJING DIDI INFINITY TECHNOLOGY AND DEVELOPMENT CO., LTD.
    Inventors: Taolue XUE, Tianming ZHANG, Zhiheng WANG, Shudong WANG, Jie LI, Hui MENG, Tianyu CHEN, Guiting DAI, Zhaohui WU, Duoqing ZHOU
  • Publication number: 20220267315
    Abstract: A novel class of inhibitors of protein kinates that are useful in the treatment of cell proliferative diseases and conditions, and especially those characterised by over-expression of CDK4, CDK6 and/or cyclin D, including certain cancers of lung, breast, brain, central nervous system, colorectal cancer and leukaemias.
    Type: Application
    Filed: August 31, 2021
    Publication date: August 25, 2022
    Inventors: Shudong Wang, Solomon Tadesse ZELEKE, Mingfeng YU
  • Publication number: 20220259203
    Abstract: A novel class of heteroaryl compounds for use in the prevention and/or treatment of proliferative diseases and conditions including cancers. The compounds are considered to be capable of inhibiting cell proliferation by inhibiting the activity of FLT3 and its mutant forms and/or other protein kinases such as CDKs.
    Type: Application
    Filed: July 10, 2020
    Publication date: August 18, 2022
    Inventors: Shudong WANG, Mingfeng YU, Yi LONG
  • Patent number: 11325900
    Abstract: A novel class of inhibitors of protein kinases useful in the treatment of proliferative cell diseases and conditions including cancers, and especially those characterised by over-expression of CDK8 and/or one or more aberrant CDK8 activity, including certain cancers of lung, breast, brain, ovary, prostate, colorectal cancer and leukaemias. The inhibitors have the general structure I.
    Type: Grant
    Filed: January 14, 2019
    Date of Patent: May 10, 2022
    Assignee: AUCENTRA HOLDINGS PTY LTD
    Inventors: Shudong Wang, Stephen Philip, Mingfeng Yu
  • Publication number: 20220065838
    Abstract: A transboundary-area water-body monitoring and early warning system includes a monitoring device placed in water body to monitor the water body. The monitoring device comprises a housing body. A control mechanism, a communication mechanism, a sensor and a power box are arranged within the housing body. Power ends of the control mechanism, of the sensor, and of the communication mechanism are electrically connected to an output end of the power box. Control terminals of the communication mechanism and of the sensor are electrically connected to a control terminal of the control mechanism. The control mechanism is configured to receive a signal sent by the sensor, and send the signal from the sensor to a background computer through the communication mechanism. The housing body comprises a lower housing and an upper housing. The lower housing is sealably connected to the upper housing.
    Type: Application
    Filed: August 12, 2021
    Publication date: March 3, 2022
    Inventors: Chengcheng Ding, Yibin Cui, Jianhua Dai, Nan Shen, Shudong Wang
  • Patent number: 11111245
    Abstract: A novel class of inhibitors of protein kinases that are useful in the treatment of cell proliferative diseases and conditions, and especially those characterised by over-expression of one or more CDK enzyme and/or by one or more aberrant CDK activity, including certain cancers of lung, breast, brain, ovary, prostate, colorectal cancer and leukaemias. The inhibitors have the general structure (I).
    Type: Grant
    Filed: February 1, 2018
    Date of Patent: September 7, 2021
    Assignee: Aucentra Therapeutics Pty Ltd
    Inventors: Shudong Wang, Sarah Al Haj Diab, Yi Long
  • Publication number: 20210139474
    Abstract: Disclosed are a tartrate of 3-(5-fluoro-4-(4-methyl-2-(methylamino)thiazol-5-yl) pyrimidin-2-ylamino)-benzenesulfonamide and a polymorph thereof, which are inhibitors of protein kinases, in particular cyclin-dependent kinase 9 (CDK9), and can be used to treat proliferative disorders, such as cancer, and other diseases related to protein kinase/CDK activity.
    Type: Application
    Filed: May 29, 2019
    Publication date: May 13, 2021
    Inventors: Shudong WANG, Hui WANG, Liqun JIANG, Jinchen LV, Wenjian JU
  • Publication number: 20210070746
    Abstract: A novel class of inhibitors of protein kinases useful in the treatment of proliferative cell diseases and conditions including cancers, and especially those characterised by over-expression of CDK8 and/or one or more aberrant CDK8 activity, including certain cancers of lung, breast, brain, ovary, prostate, colorectal cancer and leukaemias. The inhibitors have the general structure I.
    Type: Application
    Filed: January 14, 2019
    Publication date: March 11, 2021
    Inventors: Shudong WANG, Stephen PHILIP, Mingfeng YU
  • Patent number: RE49850
    Abstract: A novel class of inhibitors of protein kinases that are useful in the treatment of cell proliferative diseases and conditions, and especially those characterised by over-expression of CDK4, CDK6 and/or cyclin D, including certain cancers of lung, breast, brain, central nervous system, colorectal cancer and leukaemias.
    Type: Grant
    Filed: February 2, 2022
    Date of Patent: February 27, 2024
    Assignee: AUCENTRA THERAPEUTICS PTY LTD
    Inventors: Shudong Wang, Solomon Tadesse Zeleke, Mingfeng Yu